Home > Specialties > IVD Test Reagent/Kits, Molecular Assay, Infection, Bacteria, Clostridium difficile, DNA

IVD Test Reagent/Kits, Molecular Assay, Infection, Bacteria, Clostridium difficile, DNA

Definition : Molecular assay reagents intended to identify Clostridium difficile, a species of bacterium of the family Bacillaceae, by detecting specific genetic information of the deoxyribonucleic acid (DNA) or a DNA region that is common to all toxin-producing strains of the target bacteria.

Entry Terms : "Enterocolitis Diagnostic Reagents" , "Clostridium difficile Detection/Identification Reagents" , "Clostridium difficile Identification Reagents" , "Reagents, Clostridium difficile Toxin" , "Reagents, Molecular Assay, Infection, Bacteria, Clostridium difficile, DNA"

UMDC code : 34229

Filters
Manufacturers
Distributors
U.S.companies only
Suppress Subsidiary Companies
   

1-6 of 6 Match(es).

BD

Company Type: Parent

BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public.

Cepheid

Company Type: Parent

Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases.

Great Basin Corp

Company Type: Parent

Mayo Medical Laboratories

Company Type: Parent

Meridian Bioscience Inc

Company Type: Parent

Meridian Bioscience is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers.

ZeptoMetrix Corp

Company Type: Parent

ZeptoMetrix is a privately held company formed in 1999 to serve the diagnostic and pharmaceutical research products industries. In 2003, the company acquired the BioClinical Partners division of Impath Corporation and a highly complementary and successful partnership was formed.

1-6 of 6 Match(es).

 

Medical Product Guide Ophthalmology Management Product Guide